谷歌浏览器插件
订阅小程序
在清言上使用

ACT-1 Multicenter investigator-initiated registration-directed Phase 2 study of E7090 in subjects with advanced or recurrent solid tumors with fibroblast growth factor receptor (FGFR) gene alteration: FORTUNE trial

Neuro-Oncology Advances(2021)

引用 0|浏览4
暂无评分
关键词
fibroblast growth factor receptor,fgfr,fibroblast growth,e7090,solid tumors,investigator-initiated,registration-directed
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要